Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008. - Wikidata - wikimedia - TriplyDB

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.

http://www.wikidata.org/entity/Q30834974

about

Insights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agents Characterization of Virulence-Related Phenotypes in Candida Species of the CUG Clade.Evolution and Application of Inteins in Candida species: A Review Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014 Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients.Current perspective on emergence, diagnosis and drug resistance in Candida auris Invasive candidiasis in critical care setting, updated recommendations from "Invasive Fungal Infections-Clinical Forum", Iran.Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program Multilocus microsatellite analysis of European and African Candida glabrata isolates.Antifungal Activity of 14-Helical β-Peptides against Planktonic Cells and Biofilms of Candida Species Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients Activity of Novel Synthetic Peptides against Candida albicans.Candida krusei form mycelia along agar surfaces towards each other and other Candida species.Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes.The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit.Robust Extracellular pH Modulation by Candida albicans during Growth in Carboxylic Acids.Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002-20121 Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.Phenotypic and genotypic characteristics of Candida albicans isolates from bloodstream and mucosal infections.Drug resistance mechanisms and their regulation in non-albicans Candida species.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Current trends in outwitting resistance development in Candida infections through photodynamic and short peptide therapies: a strategic-shift from conventional antifungal agents.Future therapies targeted towards eliminating Candida biofilms and associated infections.Changing epidemiology of candidaemia in Australia.Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.Proteomic analysis of hyperadhesive Candida glabrata clinical isolates reveals a core wall proteome and differential incorporation of adhesins.The economic impact of rapid Candida species identification by T2Candida among high-risk patients.In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris.The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus.Microbial epidemiology of candidemia in neonatal and pediatric intensive care units at Children's Medical Center, Tehran.

P2860

Q26991996-6A925F95-B8FE-4D0C-B130-7F10F3A1473A Q27322862-888E596E-AE30-42FF-968E-46749F6E5373 Q28078765-974AC709-79CC-47F0-875A-2A4FCAFE4D68 Q28084765-95ECDD83-3DD1-4834-B09D-64BE9A995F67 Q31032549-886E2805-729C-4D73-9CBC-FE40FBB07C44 Q33758772-7CE43AB9-D4A7-458C-8130-3BA800FE601B Q33812143-A4C49C7C-C67C-4950-83B0-F8BDB09217FA Q34452343-C71BB690-D3BF-4770-A6E6-F5C6638F6304 Q34492906-6CF19144-9815-4C23-BC8E-7274388F8474 Q35746090-E310C6F5-406E-4CDB-B2E7-405CC0A71186 Q35903892-DB40B25E-64F5-4261-9E8E-1CC36161820D Q35946831-42237A3D-56D7-40CE-B774-7FD297EC336C Q36105815-9AB0267E-442E-4E60-8C27-BA4156591D6D Q36120361-EEF8F5E3-A868-429B-9A5B-51147CA80987 Q36154522-EC4EA947-FA86-49F2-82CF-E2F63055DB78 Q36305057-71E08188-1E0A-4B83-9698-A59ED6844956 Q36441468-4683A09A-A272-4FA7-A3DE-F3532AB71F7F Q36503873-C5094245-8234-43ED-8105-CFB94ACAB7BF Q36551326-DEBDC48C-BCAC-4509-8AF5-A249F57FAC46 Q36930128-8CFF7298-1B2E-490F-B4D7-804E82DECBAE Q37192581-A4FA92B9-213D-4B52-A047-1033FCE7E867 Q37417355-5B7C6275-B7C4-4623-A731-0992D5A24883 Q37524695-760D378F-0DD2-46CB-BCA6-AE360185DEE2 Q37580801-A375A32F-EDDD-4136-8AFA-C1606907A735 Q38589279-FA23F6EB-986D-4161-AF44-D02097E18C7D Q38610744-C8C6FF18-C8C6-4C28-9F99-744BF5B879E2 Q38684284-FB87C544-6C47-49DA-8B04-5D020A2A09B2 Q38702301-CF21D9E3-DD21-4A89-ADDB-EC0D992F9414 Q38708362-9A6C4363-0482-41F0-869E-35E9010222C6 Q38711698-D055B9E9-5362-453D-B4FF-A74C9AF6B055 Q38715450-7BF36248-8F45-43E7-92FE-E3DBC2AB1E44 Q38786061-4782B69E-DCEB-46CC-9716-A7BA4CC1323B Q38863487-1F7C6701-7B17-4D6D-A34C-4951EF7A9F79 Q38916677-01E8A620-F911-434F-B23B-37B1B884C13D Q38945209-3343E718-929F-4C34-A648-E0437D5266D2 Q39020917-F832A44A-697B-43AF-BE52-1D1D49444783 Q39092177-B3357316-1EBF-471F-BAB8-D67E49FCF34E Q39375216-29402E95-A59F-4E45-A946-6385F9123BAE Q40045635-FED7CDFB-25B7-4F66-9806-5DFCFDD06A14 Q40057634-241269DF-2784-4850-8ED8-E69387761B4A

P2860

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.

http://www.wikidata.org/entity/Q30834974

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.

@ast

Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.

@en

type

label

Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.

@ast

Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.

@en

prefLabel

Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.

@ast

Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.

@en

P1433

Q30834974-0F0A3F60-4558-4763-8AA1-F3A0DF566297

P1476

Q30834974-086AA793-04F8-4CE5-8780-D1BB9FBF6736

P2093

Q30834974-ADA5DCBC-C7E1-4F3E-AF10-43A7BDF57C8E

Q30834974-B3EAE839-D92C-40FF-B3A3-D6AE616915D0

Q30834974-C34E0AE4-CA6B-4257-84BD-2BF61B68191F

Q30834974-C74EF7DF-883F-49A8-9CCA-358A5DA5BFBF

Q30834974-EFA2637B-5A79-4ECB-AC58-5BD2F05EE3B8

Q30834974-F090AF07-089D-429D-9583-54167714293D

P2860

Q30834974-0132DA35-21E5-4698-910D-2C673AACB368

Q30834974-02C58CA4-0A39-4742-88B3-A1536CEA3C2D

Q30834974-030676F1-E223-46A4-905A-08F21D41E96F

Q30834974-031EE650-6A3E-4CF5-BFBD-A02E289BD98A

Q30834974-041F23BD-0FC7-4237-BD43-09856FFD6CB1

Q30834974-047280C0-52B5-4C48-932C-DD267782FF3B

Q30834974-0FF0FA1C-C548-4F10-A786-DA84C27F3911

Q30834974-10238779-E099-4F67-B17F-2777038343D9

Q30834974-12FB740B-148B-463D-A05D-C8F8DA18F597

Q30834974-13459A0C-8A86-4401-984F-35D5551B2C83

P304

Q30834974-CA3A6576-9E73-40E7-A2A2-67153FFB25C5

P31

Q30834974-815791B3-5006-47EB-8C19-D21A8B9407B3

P356

Q30834974-64B03242-DF1B-4DB5-960E-646A7DD93278

P407

Q30834974-A56B25BD-6B73-4BBD-8EA6-CA7CDB42FF1F

P433

Q30834974-39C3B8AF-06FB-4DDB-94C5-B6C432E3EB6E

P478

Q30834974-3373A088-7B2F-47A5-AA07-2D6211915C9B

P50

Q30834974-49B4181F-C78C-422F-A38B-8C83608ACEA1

Q30834974-53815720-CAFF-4796-B694-BF2DE8FC5FFC

P577

Q30834974-DB6B6166-A734-4801-9FE4-DD3F62C4A19F

P5875

Q30834974-2EDDCEA1-596A-44DC-B5C5-76357C0A4BC3

P698

Q30834974-85C0E713-2271-4816-BD05-52BBD7156443

P921

Q30834974-6DAF6A95-A201-4F72-9E22-CB43AE93222B

Q30834974-A3285D10-E919-421B-8BC2-201374B0C63A

Q30834974-D57CC0CA-6752-41F5-BFE7-2DA4CBA783F7

P932

Q30834974-B6A4CA82-B421-4AD1-8305-29F48062464B

P356

JOURNAL.PONE.0101510

P1433

P1476

Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.

@en

P2093

Annette C Reboli

http://www.w3.org/2001/XMLSchema#string

Billy Franks

http://www.w3.org/2001/XMLSchema#string

Coleman Rotstein

http://www.w3.org/2001/XMLSchema#string

David L Horn

http://www.w3.org/2001/XMLSchema#string

David R Andes

http://www.w3.org/2001/XMLSchema#string

Nkechi E Azie

http://www.w3.org/2001/XMLSchema#string

P2860

Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis

National surveillance of fungemia in Denmark (2004 to 2009)

Epidemiology of invasive candidiasis: a persistent public health problem

Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program

Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.

Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.

In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.

P304

e101510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0101510

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Daniel J. Diekema

Michael A Pfaller

P577

2014-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263711534

http://www.w3.org/2001/XMLSchema#string

P698

24991967

http://www.w3.org/2001/XMLSchema#string

P921

invasive species

invasion biology

P932

4081561

http://www.w3.org/2001/XMLSchema#string